A Novel Individualized Connectome-guided Approach for Precision Intermittent Theta Burst Stimulation for Depression - Trial NCT06385223
Access comprehensive clinical trial information for NCT06385223 through Pure Global AI's free database. This phase not specified trial is sponsored by Institute of Mental Health, Singapore and is currently Not yet recruiting. The study focuses on Depression. Target enrollment is 70 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Institute of Mental Health, Singapore
Timeline & Enrollment
N/A
Jun 01, 2024
Dec 31, 2026
Primary Outcome
Montgomery-Åsberg Depression Rating Scale
Summary
The Investigators propose to carry out a randomized, double-blind trial to compare the
 clinical efficacy of an individualized connectome-guided accelerated iTBS vs an
 anatomically-guided (Beam F3) accelerated iTBS. The study team will recruit both inpatients
 and outpatients who had been referred for TMS for the treatment of depression.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06385223
Device Trial